Proteome Sciences plc (LON:PRM – Get Free Report) was up 3.4% during mid-day trading on Friday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 4.64 ($0.06). Approximately 485,157 shares traded hands during mid-day trading, an increase of 165% from the average daily volume of 183,230 shares. The stock had previously closed at GBX 4.49 ($0.06).
Proteome Sciences Price Performance
The company has a market cap of £14.37 million, a P/E ratio of -3.52 and a beta of 0.07. The company has a fifty day simple moving average of GBX 3.89 and a 200-day simple moving average of GBX 3.27. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What is a Special Dividend?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Most active stocks: Dollar volume vs share volume
- DuPont’s Electronics Spinoff: The Start of Something Big
- Consumer Discretionary Stocks Explained
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
